|
|||||
|
|
||||||
Originally published as JCO Early Release 10.1200/JCO.2008.18.9035 on December 29 2008 © 2009 American Society of Clinical Oncology.
Short Delay in Initiation of Radiotherapy May Not Affect Outcome of Patients With Glioblastoma: A Secondary Analysis From the Radiation Therapy Oncology Group DatabaseFrom the Departments of Oncology, Neuro-Oncology Service, and Radiation Oncology at Tel Aviv Medical Center, Tel Aviv, Israel; Statistical Unit of the Radiation Therapy Oncology Group; Department of Radiation Oncology, Thomas Jefferson University Hospital; Philadelphia, PA; Department of Radiation Oncology, University of Wisconsin, Madison, WI; Mayo Clinic, Rochester, MN; Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Radiation Oncology, Washington University School of Medicine, St Louis, MO; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA; Department of Radiation Oncology, Gamma West Radiation Therapy, Salt Lake City, UT; and Department of Radiation Oncology, McGill University, Montreal, Quebec, Canada. Corresponding author: Deborah T. Blumenthal, MD, Department of Oncology, Tel Aviv Sourasky Medical Center, 6 Weizman St, Tel-Aviv, Israel; e-mail: deborahblumenthal{at}gmail.com. Purpose To analyze the Radiation Therapy Oncology Group (RTOG) database of patients with glioblastoma and appraise whether outcome was influenced by time to initiation of radiation therapy (RT).
Patients and Methods From 1974 through 2003, adult patients with histologically confirmed supratentorial glioblastoma were enrolled onto 16 RTOG studies. Of 3,052 enrolled patients, 197 patients (6%) were either initially rendered ineligible or had insufficient chronologic data, leaving a cohort of 2,855 patients for the present analysis. We selected four patient groups based on the interval from surgery to the start of RT:
Results No decrement in survival could be identified with increasing time to initiation of RT. Among our four temporal groupings, median survival time was unexpectedly and significantly greater in the group with the longest interval (> 4 weeks) than in those with the shortest delay ( Conclusion There is no evident reduction in survival by delaying initiation of RT within the relatively narrow constraint of 6 weeks. An unanticipated yet significantly superior outcome was identified for patients for whom RT was delayed beyond 4 weeks from surgery. Supported by Radiation Therapy Oncology Group (D.T.B.). Presented at the 11th Annual Meeting of the Society of Neuro-Oncology, November 15-19, 2006, Orlando, FL. Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
|
|
|||||||||||
|
Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|